Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer.

Jeongshim Lee Ji Hyoung Kim Mitchell Liu Andrew Bang Robert J Olson Jee Suk Chang

Published in: Journal of breast cancer (2024)

In our small dataset, 5-fraction, high-conformal ultrahypofractionated breast RT offered promising 2-year local control with minimal toxicity. Further studies are warranted to investigate the optimal dose and role in this setting.

Keyphrases

metastatic breast cancer
early stage
oxidative stress
radiation therapy
locally advanced
squamous cell carcinoma